Viartril-S vs Move Free: Which is Better for Bone Health? - Orthopedics

Share to:

Bone Strengthening Agent


Which is better for regular health maintenance, Viartril-S or Move Free? What conditions are they used to treat? Are they effective for osteoporosis caused by menopause? Does menopause syndrome include joint stiffness or pain? Thank you!

Xiu Xiu, 40~49 year old female. Ask Date: 2006/10/31

Dr. Shi Qiming reply Orthopedics


Hello: 1.
ViartrilS is the brand name, and the generic name is glucosamine.
There are many different brands available on the market with similar effects, but it is recommended to purchase products from larger pharmaceutical companies.
2.
It is primarily used as a nutritional supplement for joint cartilage and as an adjunct treatment for arthritis.
It is advisable to visit an orthopedic clinic for a physician's evaluation to determine if it is suitable for use.
Thank you.

Reply Date: 2006/10/31

More Info


When considering Viartril-S (glucosamine) and Move Free, it's essential to understand their components, intended uses, and effectiveness in relation to bone health, particularly in the context of osteoporosis and menopause-related symptoms.

Viartril-S (Glucosamine): This supplement is primarily used as a nutritional aid for joint health. It is often recommended for individuals suffering from osteoarthritis, as glucosamine is believed to help maintain cartilage and alleviate joint pain. While glucosamine is widely used, its effectiveness can vary among individuals, and it is generally considered more beneficial for early stages of joint degeneration rather than advanced osteoarthritis.

Move Free: This product contains a combination of glucosamine, chondroitin, MSM (methylsulfonylmethane), vitamin D, and calcium. The inclusion of these ingredients aims to support joint health and reduce inflammation. Research suggests that Move Free may be more effective than glucosamine alone, particularly in early osteoarthritis cases. However, its effectiveness in moderate to severe osteoarthritis is less clear, and some studies show mixed results.

Bone Health and Osteoporosis: Osteoporosis is a condition characterized by weakened bones, making them more susceptible to fractures. It is particularly common in postmenopausal women due to decreased estrogen levels, which play a crucial role in maintaining bone density. Both Viartril-S and Move Free are not specifically designed to treat osteoporosis; rather, they focus on joint health. For osteoporosis, calcium and vitamin D supplementation, along with weight-bearing exercises, are typically recommended.

Menopause and Bone Health: Menopause can lead to significant bone density loss, increasing the risk of osteoporosis. Symptoms associated with menopause, such as joint stiffness and pain, may overlap with osteoarthritis symptoms. While glucosamine and chondroitin may provide some relief for joint discomfort, they do not directly address the underlying issue of bone density loss. Therefore, while these supplements can be part of a broader strategy for managing joint health during menopause, they should not be solely relied upon for preventing or treating osteoporosis.

Joint Symptoms in Menopause: Menopause can indeed lead to joint stiffness and pain due to hormonal changes that affect joint lubrication and cartilage health. Many women report increased discomfort during this transition, which can be exacerbated by weight gain and decreased physical activity. Regular exercise, including low-impact activities like walking, swimming, or cycling, can help mitigate these symptoms by improving joint function and overall health.

In conclusion, when choosing between Viartril-S and Move Free, it may depend on individual needs and preferences. If the primary concern is joint health and early-stage osteoarthritis, Move Free may offer a more comprehensive approach due to its combination of ingredients. However, for those specifically concerned about osteoporosis, focusing on calcium and vitamin D intake, along with engaging in weight-bearing exercises, is crucial. Consulting with a healthcare provider is advisable to tailor a plan that addresses both joint health and bone density, especially during menopause.

Similar Q&A

Managing Osteoarthritis: Is Move Free the Right Supplement for You?

I have osteoarthritis in my knees, which causes pain when walking. After being diagnosed by an orthopedic doctor, I was advised to take "Wei Gu Li." Since this health supplement is not covered by health insurance, I purchased Move Free, which is manufactured in the Unit...


Dr. Yang Zhengfan reply Orthopedics
Dear Ms. Chang, you have not yet met the criteria for health insurance coverage for calcium supplements. The recommended dosage for general calcium supplements is three times a day, one tablet each time, or twice a day, two tablets each time. There are no specific safety concerns...

[Read More] Managing Osteoarthritis: Is Move Free the Right Supplement for You?


Understanding Osteoporosis: Treatment Options and Safe Activities for Seniors

Hello, doctor! My mother recently underwent a bone density test, but she couldn't clarify how much percentage of bone loss she has. She only knows that the doctor advised her to take Fosamax (Alendronate) at her own expense, one tablet per week, and that it may improve her c...


Dr. Chen Xianchang reply Rehabilitation
Hello, thank you for your inquiry. Here are my responses and suggestions: 1. Bone density test results include the Z-score (compared to age-matched peers) and T-score (compared to young adults). By looking at the percentage, you can determine the extent of osteoporosis. 2. After...

[Read More] Understanding Osteoporosis: Treatment Options and Safe Activities for Seniors


Current Advances in Osteogenesis Imperfecta Treatment and Bisphosphonate Use

Dear Dr. Lin, I am an Osteogenesis Imperfecta (OI) patient. I have been taking Fosamax (Alendronate) once a week from 2002 to 2015 for about 13 years. I remember that before starting medication, from September 2006 to December 2009, I had not experienced any major fractures for ...


Dr. Lin Ruli reply Rare Disease
1. Are there better treatment options for Osteogenesis Imperfecta (OI) in Taiwan and abroad? There are ongoing clinical trials for stem cell transplantation. 2. Does taking Fosamax (Alendronate) lead to previously strong bones becoming more prone to fractures? No, it does not. 3....

[Read More] Current Advances in Osteogenesis Imperfecta Treatment and Bisphosphonate Use


Understanding Osteoporosis Treatments: Risks of Bisphosphonates vs. Alternatives

Thank you for the doctor's response regarding osteoporosis. I would like to ask if the injection is also a bisphosphonate medication? Does it carry the same risk of osteonecrosis? I discussed this with my dentist, and he strongly opposes bisphosphonate medications. I also le...


Dr. Shi Guozheng reply Orthopedics
Raloxifene (Evista) is a selective estrogen receptor modulator that can inhibit bone resorption. Its side effect may include a slight increase in the risk of thrombosis, but this risk is not considered high. It can be used in individuals without coronary heart disease or hyperlip...

[Read More] Understanding Osteoporosis Treatments: Risks of Bisphosphonates vs. Alternatives


Related FAQ

Dietary Supplements

(Orthopedics)

Osteoporosis

(Orthopedics)

Bone Density Test

(Orthopedics)

Vertebral Arch

(Orthopedics)

Rehabilitation

(Orthopedics)

Bone Cement

(Orthopedics)

Open Fracture

(Orthopedics)

Bunion

(Orthopedics)

Medication Consultation

(Orthopedics)

Sciatica

(Orthopedics)